Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.34 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.31 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21565261 | 0.92 | GLP1R (0.54) | GLP1RLPAR2LPAR1ENPP2CNR1 | |
| SCHEMBL23031081 | 0.91 | GLP1R (0.50) | GLP1RCNR1EPHX2FAAH | |
| SCHEMBL22619268 | 0.87 | GLP1R (0.51) | GLP1RLPAR2LPAR1ENPP2GLO1 | |
| SCHEMBL27257542 | 0.87 | GLP1R (0.39) | GLP1R | |
| SCHEMBL14748066 | 0.85 | GLP1R (0.60) | GLP1RLPAR2LPAR1ENPP2EPHX2 | |
| SCHEMBL12295886 | 0.82 | GLP1R (0.59) | GLP1RCNR1EPHX2FAAH | |
| SCHEMBL12296713 | 0.82 | GLP1R (0.59) | GLP1RCNR1EPHX2FAAH | |
| SCHEMBL24822980 | 0.82 | GLP1R (0.48) | GLP1REPHX2GLO1 | |
| SCHEMBL12295313 | 0.82 | GLP1R (0.59) | GLP1RCNR1EPHX2FAAH | |
| SCHEMBL23660032 | 0.82 | GLP1R (0.48) | GLP1RLPAR2LPAR1ENPP2EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023110758-A1 | EFFECTIVE DOSES OF CNP CONJUGATES | ASCENDIS PHARMA GROWTH DISORDERS A/S (DK) | 2023-06-22 | — | — | WO | disclosed |